COMMUNIQUÉS West-GlobeNewswire

Nasus Pharma Announces FDA Clearance to Initiate Clinical Study of NS002 in the Treatment of Anaphylaxis
14/09/2026
Clinical study to evaluate NS002, the Company's investigational intranasal epinephrine powder, as a needle-free alternative to EpiPen® for patients experiencing anaphylaxis and will compare self-administration to [...]
Leios Therapeutics Announces Positive End-of-Phase 2 Meeting with FDA for 10XB-101 for Moderate-to-Severe Submental Fat Fullness
14/09/2026
Alignment Reached on Key Elements of the Phase 3 Program to Support a 505(b)(2) NDA Submission 10XB-101 Now has Clear Regulatory Path Forward LA JOLLA, Calif., Sept. 14, 2026 (GLOBE NEWSWIRE) -- Leios Therapeutics (“ [...]
Radiopharm Theranostics Selected for Late-Breaking Oral Presentation of Positive Data from Interim Analysis of U.S. Phase 2b Imaging Trial of RAD101 at 2026 Society of Neuro-Oncology Annual Meeting
14/09/2026
RAD101 PET demonstrated 93% concordance with MRI across all evaluable lesions, meeting the trial's primary endpoint Meeting with FDA planned on October 1 st to align on RAD101Phase 3 pivotal trial protocol Brain [...]
Akebia Therapeutics Announces First Patient Dosed in Phase 2 Basket Trial of Ebribafusp in Rare Complement-Mediated Kidney Diseases
14/09/2026
Open-label Phase 2 trial evaluating ebribafusp for the treatment of IgA nephropathy, lupus nephritis and C3 glomerulopathy Initial data is expected in 2027 WALTHAM, Mass., Sept. 14, 2026 (GLOBE NEWSWIRE) -- Akebia [...]
Evaxion applies its AI-Immunology™ platform in autoimmune diseases
14/09/2026
Autoimmune diseases are characterized by high unmet medical need with most current treatments only addressing symptoms. Evaxion will apply AI-Immunology™ to target underlying pathologies The unique capabilities of AI- [...]
Data Safety Monitoring Board (DSMB) Recommends Continuing BriaCell’s Phase 3 Metastatic Breast Cancer Study
14/09/2026
Independent DSMB reports no safety concerns to date and recommends continuing BriaCell's pivotal Phase 3 study of Bria-IMT™ plus an immune checkpoint inhibitor Seventh consecutive positive DSMB recommendation reinforces [...]
Beta Bionics Announces FDA Clearance of Mint™, the Company’s Transformative Patch Pump, and Unveils 3D Intelligence™ as its Next-Generation Insulin Dosing Algorithm
14/09/2026
Mint features a new and innovative patch pump architecture Full Mint U.S. commercialization expected to begin in Q1 2027 Manufacturing capacity expected to produce at least 1.5 million disposable Mint units during 2027 [...]
Cytokinetics Announces Call for Proposals for Ninth Annual Communications Grant Program
14/09/2026
Program Provides Communications and Outreach Support for Patient Advocacy Organizations Focused on Cardiovascular Diseases Deadline for Applications is October 2, 2026 SOUTH SAN FRANCISCO, Calif., Sept. 14, 2026 (GLOBE [...]
Glass House Brands Releases Mama Sue Professional Athlete Balm for Sale in California
14/09/2026
New high-potency transdermal balm was created with professional athletes in mind and is suitable for both high-performance recovery and everyday use LONG BEACH, Calif. and TORONTO, Sept. 14, 2026 (GLOBE NEWSWIRE) -- [...]
As New York Fashion Week Kicks Off, Kraig Labs Advances Spider Silk for Fashion's Next Generation of Designers
14/09/2026
Fashion industry shift puts new focus on bio-based and innovative textiles as Kraig Labs scales recombinant spider silk for potential luxury and performance applications ANN ARBOR, Mich., Sept. 14, 2026 (GLOBE NEWSWIRE [...]
Children’s National receives $56.25 million Pediatric Prevention Network award
14/09/2026
Washington, DC, Sept. 14, 2026 (GLOBE NEWSWIRE) -- Children’s National will receive $56.25 million over five years to help lead the Pediatric Prevention Network’s (PPN) work to strengthen pediatric disaster preparedness [...]
Biofrontera Announces FDA Approval of Ameluz® Red Light PDT for the Treatment of Superficial Basal Cell Carcinoma
14/09/2026
Ameluz used in conjunction with the RhodoLED lamp becomes the first and only photodynamic therapy approved in the United States to treat a skin cancer, creating an additional growth opportunity for Biofrontera’s [...]
Catalyst MedTech Helps Imaging Providers See What’s Next in Nuclear Cardiology at ASNC 2026
14/09/2026
Company to Showcase Expanded Digirad® Cardiac SPECT Portfolio, PET/CT Solutions, Windows 11 Modernization and Nationwide Imaging Service PITTSBURGH, Sept. 14, 2026 (GLOBE NEWSWIRE) -- Catalyst MedTech today announced it [...]
SafeSpace Global Announces First K-12 School Installation of Its AI-Powered Physical Safety Platform
14/09/2026
KNOXVILLE, Tenn., Sept. 14, 2026 (GLOBE NEWSWIRE) -- SafeSpace Global Corporation (OTCID: SSGC) (“SafeSpace Global” or the “Company”), a publicly traded, applied multimodal AI-powered physical safety and security [...]
Novo Nordisk A/S - share repurchase programme
14/09/2026
Bagsværd, Denmark, 14 September 2026 – On 6 May 2026, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 ( [...]
Insiders Continue Buying, as NeOnc Moves NEO100 Toward Its Next Regulatory Test
14/09/2026
DENVER, Sept. 14, 2026 (GLOBE NEWSWIRE) -- (247marketnews.com) -- NeOnc Technologies Holdings (NASDAQ: NTHI) is sending investors a signal that is impossible to ignore. The company's CEO, President and director, Amir F [...]
Ernexa Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference
14/09/2026
President and CEO Sanjeev Luther to present on Wednesday, September 16, 2026, at 12:00 p.m. ET Management available for one-on-one meetings with investors during the conference CAMBRIDGE, Mass., Sept. 14, 2026 (GLOBE [...]
Press Release: Sanofi and Cheplapharm to create new strategic partnership in mature medicines
14/09/2026
Sanofi and Cheplaphar m to create new strategic partnership i n mature medicines Paris , September 14, 2026 . Sanofi and Cheplapharm, a European leader in well-established medicines, today announced their intention to [...]
Communiqué de presse : Sanofi et Cheplapharm créent un nouveau partenariat stratégique autour des médicaments matures
14/09/2026
Sanofi et Cheplapharm créent un nouveau partenariat stratégique autour de s médicaments matures Paris, 14 septembre 2026. Sanofi et Cheplapharm, leader européen des médicaments matures, ont annoncé aujourd'hui leur [...]

Pages